4DMedical Ltd (AU:4DX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd has announced a change in the interests of its director, Andreas Fouras, with the acquisition of 775,339 unlisted options at an exercise price of $0.7534. These changes indicate a significant increase in Fouras’s stake, reflecting potential confidence in the company’s future performance. This update may interest investors keeping an eye on insider movements in the market.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.